Back to Ethypharm or All Oil Concentrates

Dosing Look-Up Table (Estimated)

0.01/g5/mg THCTrace CBD
0.05/g25/mg THCTrace CBD
0.1/g50/mg THCTrace CBD
0.15/g75/mg THCTrace CBD
0.2/g100/mg THCTrace CBD
0.25/g125/mg THCTrace CBD
0.3/g150/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

France Ethypharm
Type I: High THC
Carrier Oil
Medium-Chain Triglycerides
THC Potential Range (±10%)
CBD Potential Range (±10%)
Formulated in
Flag of United Kingdom United Kingdom

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Awaiting ETA

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Product DescriptionPatient Reviews

France About Ethypharm UK Ltd

Ethypharm Logo

Ethypharm is a specialty pharmaceutical company with European roots, focused on specific Central Nervous System (CNS) diseases and conditions, and on adding value to medicines used in Critical Care situations.

Many of our products are indicated for sensitive situations in which patients either suffer from debilitating conditions such as chronic pain or addiction, or are in a critical state. All around the world, Ethypharm employees are engaged daily to make the difference for patients’ lives by ensuring they are able to receive the right treatment at the right time and with the right support.

Ethypharm is deeply engaged in the CNS and Hospital Injectable areas, where our medicines treat patients today and our teams work on innovative solutions for tomorrow. Willing to grow beyond our recognised positions in the treatment of severe pain and opioid dependency, we are constantly screening opportunities in search for those which will respond to unmet needs in our two core areas.

  Information provided is partially community-sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)